drugset / Trial / NCT02806713

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)

NCT02806713

Phase 3 Completed 92 enrolled University of Massachusetts, Worcester
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized clinical trial using phenazopyridine to decrease voiding dysfunction after a retropubic midurethral sling operation.

Timeline

Start
2016-02
Primary completion
2017-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenazopyridine Small molecule 200 mg Oral

Indications

No indication recorded.